Jennifer L Taubert
Director; EVP, WWC. Innovative Medicine · 5 filings · Latest: Sep 30, 2026
JOHNSON & JOHNSON
MCDONALDS CORP
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
JNJ | Jennifer L Taubert | EVP, WWC. Innovative Medicine | Aug 17, 2026 | Sale | $263.36 | 15,000 | $4.0M | 194,451.001 | |
JNJ | Jennifer L Taubert | EVP, WWC. Innovative Medicine | Aug 17, 2026 | Option Exercise | $115.67 | 15,000 | $1.7M | 209,451.001 | |
JNJ | Taubert Jennifer L | — | Aug 17, 2026 | Proposed Sale | $263.36 | 15,000 | $4.0M | — | |
JNJ | Jennifer L Taubert | EVP, WWC. Innovative Medicine | Feb 15, 2026 | Option Exercise | $0.00 | 3,441 | — | 195,396.001 | |
JNJ | Jennifer L Taubert | EVP, WWC. Innovative Medicine | Feb 13, 2026 | Option Exercise | $0.00 | 28,714 | — | 206,318.001 | |
JNJ | Taubert Jennifer L | — | Sep 4, 2025 | Proposed Sale | $177.81 | 56,471 | $10.0M | — |